G. Ganem

Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer.

P. Fumoleau, V. Diéras, T. Bachelot, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.